What is the recommended dosing of Cyclobenzaprine (Flexeril) for adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Flexeril (cyclobenzaprine) dosing for teenagers typically ranges from 5-10 mg taken 2-3 times daily, with a maximum daily dose of 30 mg, as it is crucial to prioritize the safety and efficacy of the medication in this age group. For adolescents ages 15-17, treatment usually starts with 5 mg three times daily, while younger teens (12-14) may begin with 5 mg twice daily 1. The medication should be used for short periods, generally 2-3 weeks maximum, as it is not intended for long-term use. Flexeril is a muscle relaxant prescribed for acute, painful musculoskeletal conditions and works by affecting certain nerve impulses that cause muscle spasms.

Some key points to consider when prescribing Flexeril to teenagers include:

  • The medication should be used under physician supervision, as it is not FDA-approved specifically for children under 15 1
  • Side effects may include drowsiness, dry mouth, and dizziness, so teens should avoid driving or operating machinery while taking it
  • Parents should ensure the medication is taken exactly as prescribed
  • The prescribing doctor should be consulted about any concerning side effects or if pain persists beyond the treatment period

It's also important to note that while other muscle relaxants, such as baclofen and tizanidine, have been studied in various contexts, the most relevant information for Flexeril dosing in teenagers comes from studies on its efficacy and safety in musculoskeletal conditions 2, 3. However, a recent study on the safety of baclofen versus tizanidine in older adults with musculoskeletal pain found that baclofen was associated with higher incidences of injury and delirium compared to tizanidine 3, highlighting the importance of careful consideration when selecting a muscle relaxant for any patient population.

References

Research

Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2009

Research

Safety of baclofen versus tizanidine for older adults with musculoskeletal pain.

Journal of the American Geriatrics Society, 2023

Related Questions

What is the recommended dose of Cyclobenzaprine (Flexeril) for muscle pain?
What is the smallest dose, timing, and duration of Cyclobenzaprine (Flexeril) therapy?
Why is it contraindicated to use baclofen and Robaxin (methocarbamol) at the same time?
What is the effect of Cannabidiol (CBD) on muscle spasms?
What are less sedating muscle relaxant options for older patients?
What is the cause of lower abdominal discomfort, bloating, and white vaginal discharge in a 47-year-old female with stage 4 small cell lung carcinoma (SCLC) and metastases to the bone and brain, currently on immunotherapy, who recently completed a course of Augmentin (amoxicillin-clavulanate) for bacterial sinusitis?
What is the location of the lesion in a 62-year-old patient with right-sided homonymous hemianopsia, affecting the optic (nerve) tract or nerve?
What are the initial physical findings in rabies (Rabies virus infection)?
What is the diagnosis and treatment for a 12-year-old male presenting with excessive masturbation and exhibitionism, specifically exposing his genitalia to others?
Why do some doctors prohibit immediate post-surgical weight-bearing after Midfoot (MTP) foot fusion, while others allow it?
What is the clinical significance of moderate aortic valve stenosis in a 68-year-old patient with hypertension (HTN) and left bundle branch block (LBBB) on metoprolol (beta blocker), with an estimated left ventricular ejection fraction (LVEF) of 60-65%, mild mitral regurgitation, trivial aortic regurgitation, and mild tricuspid regurgitation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.